Aplidin - Dexamethasone in Relapsed/Refractory Myeloma

Clinical trial NCT01102426 · COMPLETED

Trial details

NCT number: NCT01102426
Sponsor: PharmaMar
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsed/Refractory Multiple Myeloma

Start date: 2010-06-01
Primary completion: 2017-11-01
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.